2025–2028 Strategic Plan

logo
logo

 

 

It’s time! We’ve started the important process of developing a new strategic plan that will guide Canada’s Drug Agency into the next 3 years.

This is an important opportunity for us to build on our existing strengths in evidence and health technology work while reflecting on our growing role in pharmaceutical ecosystems. We will also continue to emphasize inclusion, diversity, equity, and accessibility and Indigenous reconciliation while enhancing our collaboration with all partners, including patients, clinicians, researchers, and the life sciences sector.

Consultation Summary

As part of our strategic planning process, we hosted a series of town halls and distributed a public survey to gather input from our key partners, including patients, clinicians and clinical groups, industry, academic and research, and the broader community. 

Learn more about the themes that emerged at these engagement sessions. 

Engagement Principles

Our strategic plan development process will be driven by active and ongoing engagement to ensure that the plan reflects input from organizations and individuals who will help us advance the strategy. 

The strategic pillars and guiding principles outlined in our last strategic plan will continue to guide what we do as an organization

Strategic Pillars

Guiding Principles

Questions

If you have questions about the survey, Town Halls, or our strategic planning process, please email [email protected].

08_tech_trends_illustrations_scope_of_practice